1. Home
  2. IPSC vs JFU Comparison

IPSC vs JFU Comparison

Compare IPSC & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Century Therapeutics Inc.

IPSC

Century Therapeutics Inc.

HOLD

Current Price

$0.58

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Logo 9F Inc.

JFU

9F Inc.

HOLD

Current Price

$6.96

Market Cap

58.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IPSC
JFU
Founded
2019
2006
Country
United States
China
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
58.2M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
IPSC
JFU
Price
$0.58
$6.96
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
934.8K
12.1K
Earning Date
11-13-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
3110.57
EPS
N/A
3.04
Revenue
$113,337,000.00
$44,573,690.00
Revenue This Year
$1,590.09
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$2.43
Revenue Growth
4122.69
8.19
52 Week Low
$0.34
$1.01
52 Week High
$1.38
$9.48

Technical Indicators

Market Signals
Indicator
IPSC
JFU
Relative Strength Index (RSI) 56.92 58.72
Support Level $0.50 $4.57
Resistance Level $0.62 $9.48
Average True Range (ATR) 0.04 0.80
MACD 0.01 0.26
Stochastic Oscillator 64.59 39.01

Price Performance

Historical Comparison
IPSC
JFU

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About JFU 9F Inc.

9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.

Share on Social Networks: